Security key
B5950S113
MDxHealth SA - Ordinary shares, no par value (MDXH)
CUSIP: B5950S113
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Ordinary shares, no par value
- Total 13F shares
- 24,745,056
- Total 13F value
- $56,866,992
- Share change
- +421,243
- SEC-reported price per share
- $2.30
- Number of holders
- 50
- Value change
- +$66,259
- Number of buys
- 20
- Number of sells
- 31
- Shares outstanding
- 53,676,425
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
50
Top holders
10
MDXH full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
MDxHealth SA SEC filings
MDxHealth SA company facts
Broader feeds
Reporting periods
Holder history for CUSIP B5950S113
Recent filing periods:
Ownership snapshot
Top reported holders of MDXH - MDxHealth SA - Ordinary shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bleichroeder LP
Disclosed value leader
Bleichroeder LP
Comparable rows
15/15
Latest evidence
18 Mar 2026
13F
13D/G
3/4/5
Lead comparable stake: 15%
13D/G row: Bleichroeder LP
Showing 1-6 of 15 holder rows.
Quick read
Bleichroeder LP leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bleichroeder LP's linked filing trail.
Comparable ownership
Top 5
Bleichroeder LP
15%
EXACT SCIENCES CORP
12%
AWM Investment Company, Inc.
10%
Laurence W. Lytton
6.4%
MVM Partners, LLC
8.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bleichroeder LP |
13F
13D/G
Company
|
15%
from 13D/G
|
$26,340,649
7,378,333 shares
|
— | 31 Dec 2025 |
| EXACT SCIENCES CORP |
13D/G
Genomic Health, Inc.
|
12%
|
$22,608,510
6,441,171 shares
|
$0 | 09 Jan 2026 |
| AWM Investment Company, Inc. |
13F
13D/G
Company
|
10%
from 13D/G
|
$18,639,977
5,221,282 shares
|
— | 31 Dec 2025 |
| Laurence W. Lytton |
13D/G
LYTTON LAURENCE W
|
6.4%
|
$14,709,280
3,163,286 shares
|
-$3,655,360 | 30 Sep 2025 |
| MVM Partners, LLC |
3/4/5
13F
Director · Company
|
8.8%
|
$16,968,649
4,700,457 shares
|
— | 18 Mar 2026 |
| Eric Bednarski |
3/4/5
Director
|
8.8%
|
$10,576,028
4,700,457 shares
|
— | 18 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
50
Shares
24,745,056
Rows available
50
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
56
Q1 2026 holders
50
Holder diff
-6
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend